IP Law 101. This is the first of what will be a 3-part series on Intellectual Property provided free of charge by the Stamford office of McCarter & English, LLP. Session 1 on November 20 will aim to educate participants on the different types of intellectual property (i.e., patents, copyrights, trademarks, and trade secrets), modes of protection and key decision-points in technology life-cycles. Session 2 (Date TBD) will explore the ways intellectual property strategies can help to strengthen your company through licensing, strategic partnerships and other business relationships. Session 3 (Date TBD) will examine intellectual property issues in the context of financing and/or selling a company, including IP ownership and IP due diligence issues. Classes will be taught by attorneys from the Stamford office of McCarter & English LLP, including Bas Nabulsi and Gabe McCool.
About Basam (Bas) Nabulsi
In his twenty five-plus years as an intellectual property attorney, Mr. Nabulsi has spent almost equal amounts of time in-house and in private practice. His extensive in-house experience, broad-based engineering background and first-hand familiarity with the dynamics of product development and product commercialization have enabled him to provide valued counsel to clients across a broad range of industries and technologies.Many of Mr. Nabulsi’s clients do not have in-house counsel or in-house IP expertise. These clients look to him as their de facto “chief IP counsel”. In that role, he routinely guides clients in identifying, protecting, enforcing and licensing their intellectual property rights, both domestically and internationally, in an efficient and cost-effective manner.Mr. Nabulsi also works with many clients who are served by in-house counsel. Here too, his extensive in-house experience ensures that the advice and work product delivered to the client are responsive to the client’s specific needs and expectations.His clients include numerous industrial/manufacturing companies, universities and entrepreneurial ventures. He has particular expertise with technologies that draw on the fields of chemical engineering, mechanical engineering and electromechanical engineering as well as the dynamic fields of “business method” patents and software-based technologies. He represents numerous clients in the medical device field as well as several universities/technology transfer offices.Beyond the day-to-day work associated with building and maintaining IP portfolios, Mr. Nabulsi has particular interest and expertise in the many ways that IP interfaces with other business issues. Thus, he and his associate teams are routinely involved in transactions that involve IP assets, both on behalf of buyers and sellers. He also works closely with the firm’s corporate attorneys in financing transactions, assessing potential IP risks and vetting the many IP issues that go into the valuation process.Mr. Nabulsi is actively involved in all aspects of IP litigation, working with trial teams on cases heading to injunction hearings, trial, mediation, arbitration, and appeal. He also routinely handles post-grant administrative IP challenges, e.g., reexamination and reissue proceedings in the U.S. Patent and Trademark Office, and foresees widespread use of the new post-grant review procedures embodied in the America Invents Act.He was the founding partner of the firm’s Stamford, CT office and currently serves as its managing partner. He has participated in various strategic initiatives at the firm, including committee assignments in support of the firm’s strategic planning and implementation activities. As an active mentor of associates at the firm, he has provided hands-on training and growth opportunities to associates in multiple offices.Mr. Nabulsi is an adjunct professor at Quinnipiac Law School, teaching in the fields of IP law and IP licensing. He has spearheaded the firm’s support of the Yale Entrepreneurial Institute in New Haven, CT and has been active in the community, currently serving on the Boards of the World Affairs Forum and the Women’s Business Development Council, as well as a Commissioner on the Planning & Zoning Commission in Wilton, CT. He is a frequent speaker on IP topics, most recently speaking on FRAND issues at the 29th Annual JPPCLE Program in New York. Mr. Nabulsi was also a lecturer at the 2011 CPPC conference in Tokyo, Japan.Mr. Nabulsi has been recognized as a Connecticut Super Lawyer for 2012 and 2013.
About Gabriel McCool, PhD:
Dr. McCool is an associate at McCarter & English, LLP and has over 10 years of experience in intellectual property law.Dr. McCool’s practice primarily involves intellectual property matters pertaining to the life sciences space, including specific fields such as biotechnology, pharmaceuticals, biopharmaceuticals, and medical devices. Dr. McCool has extensive experience in the preparation of patent applications and their prosecution before the U.S. Patent and Trademark Office (USPTO), especially in technologies that include antibodies, engineered cells, photochemical tissue bonding, gene therapy, medical diagnostics, therapeutic proteins, fluorescent proteins, vaccines, structurally fortified proteins, microbial and cellular expression systems, lipid-based delivery vehicles, siRNA and RNA interference therapeutics, cardiac stents, and plastics and adhesives. In addition, Dr. McCool’s practice includes counseling clients on planning and managing effective patent filing strategies with a view towards protecting their key technological business interests in both the U.S. and in foreign jurisdictions. Dr. McCool also provides advice and counseling to assist clients with their due diligence investigations in connection with various transactions, investments, and litigation, including providing assessments as to patentability, freedom-to-operate, patent infringement, and patent validity. Besides his experience with patent prosecution before the USPTO, Dr. McCool also has experience with other USPTO proceedings, including patent reexaminations, reissues, and interferences, as well as providing assistance to clients with opposition proceedings before the European Patent Office. Dr. McCool also has experience supporting litigation before Federal Courts in connection with various patent infringement law suits, including pharmaceutical patent disputes under the Hatch-Waxman Act.Dr. McCool is co-inventor on U.S. Patent No. 6,835,820, which relates to his dissertation research.
0.00 Free IP Law event McCarter and English 0.00